Improvement in health-related quality of life in osteoporosis patients treated with teriparatide

BMC Musculoskeletal Disorders

Volumn 9, Issue , 2008, Pages

  Lau, Arthur N ^a   Ali, Sammy H ^b   Sawka, Anna M ^c   Thabane, Lehana ^a,d   Papaioannou, Alexandra ^a   Gafni, Amiram ^a,e   Adachi, Jonathan D ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d CENTRE FOR EVALUATION OF MEDICINES   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARATHYROID HORMONE[1-34]; BONE DENSITY CONSERVATION AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PAIN ASSESSMENT; PHYSICAL ACTIVITY; QUALITY OF LIFE; STRUCTURED QUESTIONNAIRE; TREATMENT OUTCOME; AGED; DAILY LIFE ACTIVITY; DOSE RESPONSE; HEALTH SURVEY; MIDDLE AGED; PAIN; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY;

ACTIVITIES OF DAILY LIVING; AGED; ANALGESICS; BONE DENSITY CONSERVATION AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PAIN; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TERIPARATIDE; TREATMENT OUTCOME;

EID: 57049171392     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-9-151     Document Type: Article

References (18)

1. Osteoporosis prevention, diagnosis and therapy. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy, JAMA 2001 285 785 795 10.1001/jama.285.6.785 11176917
2. Reduced risk of back pain following teriparatide treatment: a meta-analysis. M Nevitt P Chen DP Kiel JY Reginster RK Dore JR Zanchetta EV Glass JH Krege, Osteoporos Int 2006 17 273 280 10.1007/s00198-005-2013-2 16142502
3. Population-based study of survival after osteoporotic fractures. C Cooper EJ Atkinson SJ Jacobsen WM O'Fallon LJ Melton, Am J Epidemiol 1993 137 1001 1005 8317445
4. The clinical impact of vertebral fractures: quality of life in women with osteoporosis. DT Gold, Bone 1996 18 supplement 185S 189S 10.1016/8756-3282(95) 00500-5
5. Health impact associated with vertebral deformities: results from the European Vertebral Osteoporosis Study (EVOS). C Matthis U Weber TW O'Neill H Raspe, Osteoporos Int 1998 8 364 372 10.1007/s001980050076 10024907
6. On conducting burden-of-osteoporosis studies: a review of the core concepts and practical issues. A study carried out under the auspices of a WHO Collaborating Center. W Sedrine L Radican JY Reginster, Rheumatology 2001 40 7 14 10.1093/rheumatology/40.1.7 11157136
7. Effects of osteoporosis medications on bone quality. CL Benhamou, Joint Bone Spine 2007 74 39 47 10.1016/j.jbspin.2006.06.004 17196423
8. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. RM Neer CD Arnaud JR Zanchetta R Prince GA Gaich JY Reginster AB Hodsman EF Eriksen S Ish-Shalom HK Genant O Wang BH Mitlak, N Engl J Med 2001 344 19 1434 1441 10.1056/ NEJM200105103441904 11346808
9. Changes in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women in osteoporosis. P Chen PD Miller P Delmas DA Misurski JH Krege, J Bone Miner Res 2006 21 1785 1790 10.1359/jbmr.060802 17002571
10. Diagnosis and management of vertebral fractures in elderly patients. A Papaioannou NB Watts DL Kendler CK Yuen JD Adachi N Ferko, Am J Med 2002 113 220 228 10.1016/S0002-9343(02)01190-7 12208381
11. Development and validation of the mini-osteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis Quality of Life Study Group. DJ Cook GH Guyatt JD Adachi RS Epstein EF Juniper PA Austin J Clifton CJ Rosen CR Kessenich JL Stock J Overdorf PD Miller AL Erickson MR McClung BL McClung LE Griffith G Ioannidis, Osteoporos Int 1999 10 3 207 13 10.1007/s001980050217 10525712
12. Measuring change over time: assessing the usefulness of evaluative instruments. G Guyatt S Walter G Norman, J Chronic Dis 1987 40 171 178 10.1016/0021-9681(87)90069-5 3818871
13. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. EF Juniper GH Guyatt A Willan LE Griffith, J Clin Epidemiol 1994 47 81 87 10.1016/0895-4356(94)90036-1 8283197
14. The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. JD Adachi G Ioannidis WP Olszynski JP Brown DA Hanley RJ Sebaldt A Petrie A Tenenhouse GF Stephenson A Papaioannou GH Guyatt CH Goldsmith, BMC Musculoskelet Disord 2002 3 11 11967146 10.1186/1471-2474-3-11
15. Prevelance and incidence of vertebral deformities. LJ Melton AW Lane C Cooper R Eastell WM O'Fallon BL Riggs, Osteoporos Int 1993 3 113 119 10.1007/BF01623271 8481586
16. Lengthy hospitalization associated with vertebral fractures despite control for comorbid conditions. A Papaioannou JD Adachi W Parkinson G Stephenson M Bedard, Osteoporos Int 2001 12 870 874 10.1007/s001980170039 11716191
17. Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures. AM Oleksik S Ewing W Shen NM van Schoor P Lips, Osteoporos Int 2005 16 8 861 870 10.1007/s00198-004-1774-3 15558238
18. Beyond randomized control trials: A critical comparison of trials with non-randomized studies. H Toft Sorensen T Lash K Rothman, Hepatology 2006 44 1075 1082 10.1002/hep.21404 17058242